Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RBM12B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | SLC2A4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | AGPAT5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | EIF2S2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | E2F3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZNF730 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | DCHS1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
mRNA | SOX4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | EEF2KMT | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | NEUROG3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |